INnovation

INnovation

How one founder is using machine learning to change the rare disease diagnostic journey

By Karen Roberts, RARE Revolution

17 August 2026

INnovation

Introducing the Hugo Fellows: insights from the frontline of rare disease research

By Emma Bishop, RARE Revolution

10 August 2026

INnovation

MND: research discovers signs of disease up to 20 years before onset

By Karen Roberts, RARE Revolution

3 August 2026

INnovation

Hugo Fellows: securing the future of rare diagnostics

By Emma Bishop, RARE Revolution

3 August 2026

INnovation

Using AI to transform rare disease clinical trials

By Becca Bull, RARE Revolution

27 July 2026

INnovation

Single patient record: what benefits could it have for patients?

By Karen Roberts, RARE Revolution

20 July 2026

INnovation

Understanding comes first, decisions follow: trialport brings clarity to the clinical trial environment

By Emma Bishop, RARE Revolution

1 June 2026

INnovation

The failure of the ‘usual suspects’ approach to life science recruitment

By CONTRIBUTOR

18 May 2026

INnovation

From months to weeks: how The BioForge is using AI to unblock the slowest part of drug development

By Emma Bishop, RARE Revolution

11 May 2026

INnovation

The evidence that trials leave behind: Vitaccess and the MGFA look to address this gap in myasthenia gravis

By Emma Bishop, RARE Revolution

13 April 2026

INnovation

The age of dAIgnosis: How is AI impacting access to health information?

By Florence Cornish, RARE Revolution

23 March 2026

INnovation

How real-time, real-world data unlocks precision in rare disease marketing

By CONTRIBUTOR

2 March 2026

INnovation

AI is creating a new Darwinian jobs market where the super employee is king

By CONTRIBUTOR

9 February 2026

INnovation

Is it possible to predict and prevent seizures? The promise of a new algorithm

By Florence Cornish, RARE Revolution

2 February 2026

INnovation

My daughter is going blind. We are building a new model for rare disease gene therapy

By CONTRIBUTOR

26 January 2026

INnovation

Programming the future of rare disease: ABYA Genomics’ AI revolution

By Nicola Miller, RARE Revolution

26 January 2026

INnovation

Cytochroma making a splash with Morgan Stanley at Time Square

By Nicola Miller, RARE Revolution

15 December 2025

1 2 Next »